Ozempic / GLP-1 Lawsuits

Public Search Interest in Ozempic Side Effects and Recalls Rises Sharply

Published Aug 24, 2026Updated Aug 24, 2026

By People's Justice

What happened

Google Trends data recorded a sharp week-over-week rise in searches for terms including "ozempic news today" (up 950%), "ozempic news" (up 750%), "ozempic recall 2025" (up 130%), and related side-effect searches such as "common side effects of ozempic" and "side effects of semaglutide" (each up 350%). Several terms, including "what is ozempic 2.0" and "pet food recall news," registered as Google Trends "breakout" searches, indicating unusually large increases in volume.

Event date: Aug 24, 2026

Source: trends.google.com

Ozempic / GLP-1 Lawsuits case guide Check eligibility

Related news

Oct 2, 2026
Ozempic / GLP-1 Lawsuits
FDA Flags GLP-1 Pens That May Contain No Medication; New Research Examines Additional Risks
According to a report from MedShadow Foundation, the FDA issued a warning that some GLP-1 receptor agonist pens may contain no medication. The report was published alongside separate coverage of ongoing gastroparesis litigation and new peer-reviewed research examining GLP-1 drugs and bipolar disorder hospitalization, pregnancy complications, and orofacial adverse events.
Source: news.google.com
Oct 1, 2026
Ozempic / GLP-1 Lawsuits
FDA Flags GLP-1 Pens That May Contain No Medication; New Research Published
A report from MedShadow Foundation, carried via Google News, noted an FDA warning that some GLP-1 injector pens may contain no medication. Separately, newly published research examined GLP-1 receptor agonists in connection with orofacial adverse events, maternal pregnancy outcomes, and psychiatric hospitalization in bipolar disorder.
Source: news.google.com
Aug 25, 2026
Ozempic / GLP-1 Lawsuits
Search Interest in Ozempic Recalls and Side Effects Surges
Google Trends data recorded sharp week-over-week increases in searches for terms including "ozempic news" (up 750%), "ozempic news today" (up 950%), "ozempic recall 2025" (up 130%), and "side effects of semaglutide" (up 350%), along with breakout interest in "what is ozempic 2.0." This reflects rising public search activity, not a confirmed regulatory, legal, or court development.
Source: trends.google.com